Home
VALN
VALN News

Latest Valneva SE (VALN) News on January 19, 2025

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

GlobeNewswire

13 days ago

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

VALNEVA Declaration of shares and voting rights: December 31, 2024

GlobeNewswire

16 days ago

VALNEVA Declaration of shares and voting rights: December 31, 2024

Exploring High Growth Tech Stocks for December 2024

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks for December 2024

Valneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia

TipRanks

a month ago

Valneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

GlobeNewswire

a month ago

Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

VALNEVA - Declaration of shares and voting rights: November 30, 2024

GlobeNewswire

a month ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

GlobeNewswire

2 months ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

GlobeNewswire

2 months ago

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Zacks

2 months ago

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

MT Newswires

2 months ago

Valneva Submits Label Extension Application to US FDA for Chikungunya Vaccine IXCHIQ

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

GlobeNewswire

2 months ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

High Growth Tech Stocks To Explore This November 2024

Simply Wall St.

2 months ago

High Growth Tech Stocks To Explore This November 2024

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

The Wall Street Journal

2 months ago

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

GlobeNewswire

2 months ago

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

GlobeNewswire

2 months ago

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...

GuruFocus.com

2 months ago

Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...

Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

2 months ago

Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates

Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For

GuruFocus.com

2 months ago

Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For

VALNEVA - Declaration of shares and voting rights: October 31, 2024

GlobeNewswire

2 months ago

VALNEVA - Declaration of shares and voting rights: October 31, 2024

High Growth Tech Stocks in France to Watch October 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks in France to Watch October 2024

Lectra And 2 Other High Growth Tech Stocks In France

Simply Wall St.

3 months ago

Lectra And 2 Other High Growth Tech Stocks In France

Exploring 3 High Growth Tech Stocks In France

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks In France

Valneva to Present on Chikungunya at Several Leading Scientific Conferences

GlobeNewswire

3 months ago

Valneva to Present on Chikungunya at Several Leading Scientific Conferences

High Growth Tech Stocks In France Featuring 3 Promising Companies

Simply Wall St.

3 months ago

High Growth Tech Stocks In France Featuring 3 Promising Companies

MT Newswires

3 months ago

Valneva, LimmaTech Get FDA Fast Track Designation for Shigellosis Vaccine Candidate

Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V

GlobeNewswire

3 months ago

Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V

High Growth Tech Stocks In France October 2024

Simply Wall St.

3 months ago

High Growth Tech Stocks In France October 2024

Valneva Hosts Investor Day in New York City

GlobeNewswire

3 months ago

Valneva Hosts Investor Day in New York City

Valneva SE (INRLF) (H1 2024) Earnings Call Highlights: Navigating Growth Amidst Revenue Challenges

GuruFocus.com

3 months ago

Valneva SE (INRLF) (H1 2024) Earnings Call Highlights: Navigating Growth Amidst Revenue Challenges

Exclusive Networks And 2 High Growth Tech Stocks In France

Simply Wall St.

3 months ago

Exclusive Networks And 2 High Growth Tech Stocks In France

Exploring Three High Growth Tech Stocks in France

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in France

Valneva SE - Declaration of shares and voting rights - September 30, 2024

GlobeNewswire

4 months ago

Valneva SE - Declaration of shares and voting rights - September 30, 2024

Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET

GlobeNewswire

4 months ago

Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET

Valneva eyes teenage label for chikungunya vaccine in Europe and Canada

Pharmaceutical Technology

4 months ago

Valneva eyes teenage label for chikungunya vaccine in Europe and Canada

Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada

GlobeNewswire

4 months ago

Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada

Valneva Announces the Success of its Private Placement Raising approximately €60 Million

GlobeNewswire

4 months ago

Valneva Announces the Success of its Private Placement Raising approximately €60 Million

Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros

GlobeNewswire

4 months ago

Valneva Announces the Launch of a Private Placement of Ordinary Shares for Approximately 60 Million Euros

Esker And 2 Other High Growth Tech Stocks In France

Simply Wall St.

4 months ago

Esker And 2 Other High Growth Tech Stocks In France

VALNEVA - Declaration of shares and voting rights: August 31, 2024

GlobeNewswire

4 months ago

VALNEVA - Declaration of shares and voting rights: August 31, 2024

Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study

Benzinga

5 months ago

Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study

Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock

Zacks

5 months ago

Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock

Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster

Clinical Trials Arena

5 months ago

Valneva and Pfizer report positive data from trial of Lyme disease vaccine booster

Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate

GlobeNewswire

5 months ago

Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate

Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know

Zacks

5 months ago

Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know

High Growth Tech Stocks in France Featuring Lectra and Two More

Simply Wall St.

5 months ago

High Growth Tech Stocks in France Featuring Lectra and Two More

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3%

Zacks

5 months ago

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3%

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

5 months ago

Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates

VALNEVA - Declaration of shares and voting rights: July 31, 2024

GlobeNewswire

5 months ago

VALNEVA - Declaration of shares and voting rights: July 31, 2024

Valneva and LimmaTech partner for shigellosis vaccine development

Pharmaceutical Technology

6 months ago

Valneva and LimmaTech partner for shigellosis vaccine development

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

GlobeNewswire

6 months ago

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect?

Zacks

6 months ago

Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect?

Valneva and CEPI expand deal for chikungunya vaccine trials

Clinical Trials Arena

6 months ago

Valneva and CEPI expand deal for chikungunya vaccine trials

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine

GlobeNewswire

6 months ago

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine

Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026

Benzinga

6 months ago

Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion

GlobeNewswire

6 months ago

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine

Zacks

6 months ago

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine

Declaration of shares and voting rights - Valneva SE - June 30, 2024

GlobeNewswire

6 months ago

Declaration of shares and voting rights - Valneva SE - June 30, 2024

MT Newswires

7 months ago

Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine

Valneva’s chikungunya vaccine gains EC’s market authorisation

Pharmaceutical Technology

7 months ago

Valneva’s chikungunya vaccine gains EC’s market authorisation

Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®

GlobeNewswire

7 months ago

Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board

GlobeNewswire

7 months ago

Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board

Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval

Zacks

7 months ago

Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval

MT Newswires

7 months ago

Valneva's Chikungunya Vaccine Receives Health Canada's Approval

Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®

GlobeNewswire

7 months ago

Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

GlobeNewswire

7 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

VALNEVA - Declaration of shares and voting rights: May 31, 2024

GlobeNewswire

7 months ago

VALNEVA - Declaration of shares and voting rights: May 31, 2024

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

GlobeNewswire

7 months ago

Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases

GlobeNewswire

8 months ago

Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases

MT Newswires

8 months ago

Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee

Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine

GlobeNewswire

8 months ago

Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine

Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer

GlobeNewswire

8 months ago

Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer

Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine

GlobeNewswire

8 months ago

Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire

8 months ago

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Declaration of shares and voting rights April 30, 2024 - VALNEVA SE

GlobeNewswire

8 months ago

Declaration of shares and voting rights April 30, 2024 - VALNEVA SE

Declaration of voting rights - Valneva SE, March 2024

GlobeNewswire

9 months ago

Declaration of voting rights - Valneva SE, March 2024

Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

GlobeNewswire

10 months ago

Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F

GlobeNewswire

10 months ago

Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F

Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript

Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.

GlobeNewswire

10 months ago

Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.

Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire

10 months ago

Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed

GlobeNewswire

10 months ago

Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed

VALNEVA Declaration of shares and voting rights - February 29, 2024

GlobeNewswire

10 months ago

VALNEVA Declaration of shares and voting rights - February 29, 2024

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

GlobeNewswire

a year ago

Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences

U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®

GlobeNewswire

a year ago

U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®

Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance

GlobeNewswire

a year ago

Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance

VALNEVA: Declaration of shares and voting rights - January 31, 2024

GlobeNewswire

a year ago

VALNEVA: Declaration of shares and voting rights - January 31, 2024

Valneva sells regulatory ‘fast pass’ for $103M

BioPharma Dive

a year ago

Valneva sells regulatory ‘fast pass’ for $103M

Valneva Announces Sale of Priority Review Voucher for $103 Million

GlobeNewswire

a year ago

Valneva Announces Sale of Priority Review Voucher for $103 Million

Deluxe Reports Fourth Quarter and Full Year 2023 Results; Affirms Full Year 2024 Outlook

Business Wire

a year ago

Deluxe Reports Fourth Quarter and Full Year 2023 Results; Affirms Full Year 2024 Outlook

Byline Bancorp (NYSE:BY) Has Affirmed Its Dividend Of $0.09

Simply Wall St.

a year ago

Byline Bancorp (NYSE:BY) Has Affirmed Its Dividend Of $0.09

12 Most Promising Green Stocks According to Analysts

Insider Monkey

a year ago

12 Most Promising Green Stocks According to Analysts

With 85% institutional ownership, REX American Resources Corporation (NYSE:REX) is a favorite amongst the big guns

Simply Wall St.

a year ago

With 85% institutional ownership, REX American Resources Corporation (NYSE:REX) is a favorite amongst the big guns

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Preferred Bank (NASDAQ:PFBC) Q4 2023 Earnings Call Transcript

4D Molecular Therapeutics Inc CEO David Kirn Sells 5,696 Shares

GuruFocus.com

a year ago

4D Molecular Therapeutics Inc CEO David Kirn Sells 5,696 Shares

Interface Circular Approach Recognized by The World Economic Forum and McKinsey as a Circularity Lighthouse in the Built Environment

Business Wire

a year ago

Interface Circular Approach Recognized by The World Economic Forum and McKinsey as a Circularity Lighthouse in the Built Environment

Lawmakers press Steward Health Care over reports of ‘grave financial distress’

Healthcare Dive

a year ago

Lawmakers press Steward Health Care over reports of ‘grave financial distress’

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Zacks

a year ago

Zacks Industry Outlook Highlights American Water Works, California Water Service, SJW Group and Consolidated Water

Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program

Zacks

a year ago

Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program

Mercury Introduces Direct RF System-On-Module Powered by Intel Agilex FPGA

GlobeNewswire

a year ago

Mercury Introduces Direct RF System-On-Module Powered by Intel Agilex FPGA

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)

StockStory

a year ago

Personal Care Stocks Q3 Recap: Benchmarking Herbalife (NYSE:HLF)

Share on Social Networks: